Patterns of co-occurrence of rare and threatened species in winter arable plant communities of Italy

Detecting patterns of species co-occurrence is among the main tasks of plant community ecology. Arable plant communities are important elements of agroecosystems, because they support plant and animal biodiversity and provide ecosystem services. These plant communities are shaped by both agricultural and environmental drivers. The pressure of intensive agriculture worldwide has caused the decline of many characteristic arable species and communities. Italy is the European country where arable plant biodiversity is the best preserved. In this study, we assessed the patterns of co-occurrence of rare and threatened arable plants in 106 plots of winter arable vegetation located from Piedmont to Calabria, in the mainland part of the country. For this purpose, we based our investigation on the analysis of a recently acquired dataset and on the European list of rare and threatened arable plants. We highlight how dierent species of conservation interest tend to occur in the same community. On the other hand, generalist and more competitive taxa show similar patterns of co-occurrence. We suggest that single species of conservation value could be suitable indicators of a well-preserved community. On the other hand, to be eective, conservation strategies should target the whole community, rather than single species

Development of a new GIS-based method to detect high natural value farmlands. A case study in central Italy

An original method for the identification of High Natural Value farmlands is presented. Gathering information about land use (CORINE Land Cover), geomorphology (elevation and Terrain Ruggedness Index) and remote sensing data in a GIS environment we were able to develop a new detection process; its application to a wide sector of central Italy, in areas characterized by high biodiversity and relevant agronomic and cultural value, is presented. Thus, a new tool for diminishing sampling efforts and economic and time wastes in territorial studies is provided

The weed vegetation of the bean “Fagiolo Cannellino di Atina” and the red pepper “Peperone di Pontecorvo” PDO crops (Latium, central Italy)

The weed vegetation of the bean “Fagiolo Cannellino di Atina” (Phaseolus vulgaris L.) and the red pepper “Peperone di Pontecorvo” (Capsicum annuum L.) PDO (Protected Designation of Origin) crops was surveyed by means of 16 relevés, sampled in four farms of southern Latium during July 2019. The relevés were subjected to multivariate analysis, which revealed that the two crops are weeded by vegetation types referable to two different subassociations of Panico-Polygonetum persicariae (Spergulo-Erodion, Eragrostietalia, Digitario-Eragrostietea). Namely, communities colonizing bean fields, which are more mesophilous and richer in Eurasian taxa, are ascribable to the subassociation sorghetosum halepensis. Communities colonizing red pepper fields, which are more thermophilous and richer in Mediterranean taxa, are ascribable to the subassociation cyperetosum rotundi. Floristic, structural, and chorological features of the communities are discussed in relation to environmental factors and agricultural management

Efficient and reversible CO2 capture in bio-based ionic liquids solutions

Choline/amino acid-based ionic liquids were synthetized via ionic metathesis and their CO2 absorption performances evaluated by employing different experimental approaches. In order to overcome any viscosity-related problem, dimethyl sulfoxide (DMSO) was employed as solvent. IL-DMSO solutions with different IL concentrations were evaluated as absorbents for CO2, also investigating their good cyclability as desirable for real industrial CO2 capture technologies. 1H-NMR and in-situ ATR-IR experiments were the toolbox to study the CO2 chemical fixation mechanism under different experimental conditions, proving the formation of distinct chemical species (carbamic acid and/or ammonium carbamate). In general, these ILs demonstrated molar uptakes higher than classical 0.5 mol CO2/mol IL and the capacity to release CO2 in extremely mild conditions. The possible biological adverse effects were also analyzed, for the first time, in zebrafish (Danio rerio) during the development, by assessing for different toxicological endpoints, proving the non-toxicity and high biocompatibility of these bio-inspired ILs

La flora commensale delle colture D.O.P. "Peperone di Pontecorvo" e "Fagiolo cannellino di Atina" (Lazio meridionale)

Il “Peperone di Pontecorvo” (Capsicum annuum L. ‘Cornetto di Pontecorvo’) e il “Fagiolo cannellino di Atina” (Phaseolus vulgaris L. ‘Cannellino di Atina’) (Fig. 1) sono due colture annuali a ciclo estivo-autunnale della Provincia di Frosinone (Lazio), che hanno ottenuto il marchio D.O.P. nel 2010. I disciplinari di produzione prevedono la semina primaverile (peperone) o estiva (fagiolo), l’irrigazione e, infine, la raccolta estiva o autunnale. Per quanto riguarda le concimazioni e il diserbo chimico, questi sono consentiti per il peperone, mentre vengono vietati per il fagiolo. Le aree di produzione sono localizzate rispettivamente nella bassa Valle del Liri (a circa 50 m s.l.m.) e nella media Valle di Comino (a circa 400 m s.l.m.) e sono entrambe estremamente ridotte (poche centinaia di km2), fatto che conferisce alle due colture un intimo legame con il territorio. I substrati sono di natura alluvionale ed il fitoclima è Temperato Submediterraneo, a contatto con la fascia a fitoclima Mediterraneo nel caso di Pontecorvo (Pesaresi et al. 2017). Data l’utilità dello studio della flora commensale delle colture, sia dal punto di vista naturalistico-ambientale sia agronomico, e la totale mancanza di informazioni su questa per il “Peperone di Pontecorvo” e il “Fagiolo cannellino di Atina”, nel mese di luglio 2019 è stata effettuata un’indagine floristica in quattro aziende campione, due produttrici di peperoni e due di fagioli (Commissione Europea 2019). Il rilevamento è stato svolto tramite plot di area fissa di dimensioni 1 × 16 m, effettuando un rilievo al centro di ogni appezzamento coltivato (Chytrý, Otýpková 2003, Güler et al. 2016). Ad ogni agricoltore è stato, inoltre, chiesto di compilare un questionario riguardante le principali pratiche agronomiche effettuate. In totale sono stati censiti 52 taxa di piante vascolari, 35 nei campi di peperone e 27 nei campi di fagiolo, riferibili a 43 generi e 21 famiglie; le famiglie più rappresentate sono Asteraceae, Poaceae, Euphorbiaceae, Polygonaceae e Brassicaceae ed il genere più rappresentato è Euphorbia. I taxa più frequenti sono Amaranthus retroflexus L., Convolvulus arvensis L., Portulaca oleracea L., Sorghum halepense (L.) Pers., Cyperus rotundus L., Sonchus oleraceus L., Digitaria sanguinalis (L.) Scop., Xanthium italicum Moretti e Chenopodium album L. subsp. album. Tra i molti taxa ampiamente diffusi, ne sono stati rinvenuti alcuni poco comuni in regione (Anzalone et al. 2010): Chrozophora tinctoria (L.) A.Juss., Euphorbia chamaesyce L., Lotus hispidus DC. e Visnaga daucoides Gaertn. L’analisi strutturale (Fig. 2a) ha evidenziato la presenza di una flora prevalentemente terofitica (67% di taxa annuali nelle colture di fagiolo, 82% in quelle di peperone), e subordinatamente geofitica ed emicriptofitica. La maggior incidenza di terofite nella flora commensale dei peperoni è riconducibile ad un contesto fitoclimatico caratterizzato da una maggiore aridità, comunque presente nonostante le irrigazioni. Tra le geofite, rilevante è il ruolo rivestito dalle rizomatose Cyperus rotundus L., nelle colture di peperone, e Sorghum halepense (L.) Pers., in quelle di fagiolo; entrambe queste specie sono infestanti di notevole rilevanza in agricoltura (Holm et al. 1977). In termini corologici (Fig. 2b), la flora totale è caratterizzata da una notevole incidenza di neofite (maggiormente rappresentate nella flora commensale dei peperoni) e cosmopolite (più presenti in quella dei fagioli). Tra le neofite, tutte invasive e quasi tutte di provenienza americana, vi sono Amaranthus hybridus L. subsp. hybridus, A. retroflexus L., Artemisia verlotiorum Lamotte, Datura stramonium L., Erigeron canadensis L., E. sumatrensis Retz., Euphorbia maculata L., E. prostrata Aiton e Veronica persica Poir. Tra i taxa ad ampia distribuzione sono presenti Chenopodium album L. subsp. album, Cynodon dactylon (L.) Pers., Cyperus rotundus L., Digitaria sanguinalis (L.) Scop., Echinochloa crusgalli (L.) P.Beauv. subsp. crusgalli, Euphorbia helioscopia L., Persicaria maculosa Gray, Portulaca oleracea L. e Rumex crispus L. Le archeofite sono invece esclusive delle colture di fagiolo e sono rappresentate da Abutilon theophrasti Medik. e Sorghum halepense (L.) Pers. Seguono per importanza i taxa eurimediterranei, più rappresentati nelle colture di peperoni. L’applicazione degli indici di Ellenberg (Pignatti 2005, Domina et al. 2018) ha evidenziato come la flora commensale dei peperoni sia leggermente più termofila ed eliofila, coerentemente con il fitoclima, e leggermente più nitrofila, come conseguenza delle concimazioni chimiche. In generale, l’indagine ha confermato la spiccata omogeneità della flora commensale delle colture a ciclo estivo nel Lazio, evidenziando notevoli affinità tra i contingenti floristici indagati e quelli, recentemente studiati, delle colture di mais (Abbate et al. 2013, Fanfarillo et al. 2019)

Global and Regional IUCN Red List Assessments: 5

In this contribution, the conservation status of four vascular plants according to IUCN categories and criteria are presented. It includes the assessment of Arceuthobium oxycedri (DC.) M.Bieb., Ionopsidium albiflorum Durieu, Trifolium latinum Sebast., and Vicia incisa M.Bieb. at a Regional level (Italy)

Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death

BACKGROUND: A systemic inflammatory response is observed after cardiopulmonary resuscitation. We investigated two novel inflammatory markers, pentraxin 3 (PTX3) and soluble suppression of tumorigenicity 2 (sST2), in comparison with the classic high-sensitivity C-reactive protein (hsCRP), for prediction of early multiple organ dysfunction syndrome (MODS), early death, and long-term outcome after out-of-hospital cardiac arrest. METHODS: PTX3, sST2, and hsCRP were assayed at ICU admission and 48 h later in 278 patients. MODS was defined as the 24 h non-neurological Sequential Organ Failure Assessment (SOFA) score 6512. Intensive care unit (ICU) death and 12-month Cerebral Performance Category (CPC) were evaluated. RESULTS: In total, 82% of patients survived to ICU discharge and 48% had favorable neurological outcome at 1 year (CPC 1 or 2). At ICU admission, median plasma levels of hsCRP (2.8 mg/L) were normal, while levels of PTX3 (19.1 ng/mL) and sST2 (117 ng/mL) were markedly elevated. PTX3 and sST2 were higher in patients who developed MODS (p<0.0001). Admission levels of PTX3 and sST2 were also higher in patients who died in ICU and in those with an unfavorable 12-month neurological outcome (p<0.01). Admission levels of PTX3 and sST2 were independently associated with subsequent MODS [OR: 1.717 (1.221-2.414) and 1.340, (1.001-1.792), respectively] and with ICU death [OR: 1.536 (1.078-2.187) and 1.452 (1.064-1.981), respectively]. At 48 h, only sST2 and hsCRP were independently associated with ICU death. CONCLUSIONS: Higher plasma levels of PTX3 and sST2, but not of hsCRP, at ICU admission were associated with higher risk of MODS and early death

Notulae to the Italian alien vascular flora 6

In this contribution, new data concerning the distribution of vascular flora alien to Italy are presented. It includes new records, confirmations, exclusions, and status changes for Italy or for Italian administrative regions of taxa in the genera Acalypha, Acer, Canna, Cardamine, Cedrus, Chlorophytum, Citrus, Cyperus, Epilobium, Eucalyptus, Euphorbia, Gamochaeta, Hesperocyparis, Heteranthera, Lemna, Ligustrum, Lycium, Nassella, Nothoscordum, Oenothera, Osteospermum, Paspalum, Pontederia, Romulea, Rudbeckia, Salvia, Sesbania, Setaria, Sicyos, Styphnolobium, Symphyotrichum, and Tradescantia. Nomenclature and distribution updates, published elsewhere, and corrigenda are provided as supplementary material

Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

BACKGROUND: Pre-exposure vaccination with MVA-BN has been widely used against mpox to contain the 2022 outbreak. Many countries have defined prioritized strategies, administering a single dose to those historically vaccinated for smallpox, to achieve quickly adequate coverage in front of low supplies. Using epidemiological models, real-life effectiveness was estimated at approximately 36%–86%, but no clinical trials were performed. Few data on MVA-BN immunogenicity are currently available, and there are no established correlates of protection. Immunological response in PLWH in the context of the 2022 outbreak was also poorly described. METHODS: Blood samples were collected from participants eligible for pre-exposure MVA-BN vaccination before (T1) receiving a full course of vaccine (single-dose for vaccine-experienced or smallpox-primed and two-dose for smallpox vaccine-naïve or smallpox non-primed) and one month after the last dose (T2 and T3, respectively). MPXV-specific IgGs were measured by in-house immunofluorescence assay, using 1:20 as screening dilution, MPXV-specific nAbs by 50% plaque reduction neutralization test (PRNT50, starting dilution 1:10), and IFN-γ-producing specific T cells to MVA-BN vaccine, by ELISpot assay. Paired or unpaired t-test and Wilcoxon or Mann–Whitney test were used to analyse IgG and nAbs, and T-cell response, as appropriate. The probability of IgG and nAb response in vaccine-experienced vs. vaccine-naïve was estimated in participants not reactive at T1. The McNemar test was used to evaluate vaccination's effect on humoral response both overall and by smallpox vaccination history. In participants who were not reactive at T1, the proportion of becoming responders one month after full-cycle completion by exposure groups was compared by logistic regression and then analysed by HIV status strata (interaction test). The response was also examined in continuous, and the Average Treatment Effect (ATE) of the difference from baseline to schedule completion according to previous smallpox vaccination was estimated after weighting for HIV using a linear regression model. Self-reports of adverse effects following immunization (AEFIs) were prospectively collected after the first MVA-BN dose (T1). Systemic (S-AEFIs: fatigue, myalgia, headache, GI effects, chills) and local (L-AEFIs: redness, swelling, pain) AEFIs were graded as absent (grade 0), mild (1), moderate (2), or severe (3). The maximum level of severity for S-AEFIs and L-AEFIs ever experienced over the 30 days post-dose by vaccination exposure groups were analysed using a univariable multinomial logistic regression model and after adjusting for HIV status; for each of the symptoms, we also compared the mean duration by exposure group using an unpaired t-test. FINDING: Among the 164 participants included, 90 (54.8%) were smallpox vaccine-experienced. Median age was 49 years (IQR 41–55). Among the 76 (46%) PLWH, 76% had a CD4 count >500 cells/μL. There was evidence that both the IgG and nAbs titers increased after administration of the MVA-BN vaccine. However, there was no evidence for a difference in the potential mean change in humoral response from baseline to the completion of a full cycle when comparing primed vs. non-primed participants. Similarly, there was no evidence for a difference in the seroconversion rate after full cycle vaccination in the subset of participants not reactive for nAbs at T1 (p = 1.00 by Fisher's exact test). In this same analysis and for the nAbs outcome, there was some evidence of negative effect modification by HIV (interaction p-value = 0.17) as primed people living with HIV (PLWH) showed a lower probability of seroconversion vs. non-primed, and the opposite was seen in PLWoH. When evaluating the response in continuous, we observed an increase in T-cell response after MVA-BN vaccination in both primed and non-primed. There was evidence for a larger increase when using the 2-dose vs. one-dose strategy with a mean difference of −2.01 log2 (p ≤ 0.0001), after controlling for HIV. No evidence for a difference in the risk of developing any AEFIs of any grade were observed by exposure group, except for the lower risk of grade 2 (moderate) fatigue, induration and local pain which was lower in primed vs. non-primed [OR 0.26 (0.08–0.92), p = 0.037; OR 0.30 (0.10–0.88), p = 0.029 and OR 0.19 (0.05–0.73), p = 0.015, respectively]. No evidence for a difference in symptom duration was also detected between the groups. INTERPRETATION: The evaluation of the humoral and cellular response one month after the completion of the vaccination cycle suggested that MVA-BN is immunogenic and that the administration of a two-dose schedule is preferable regardless of the previous smallpox vaccination history, especially in PLWH, to maximize nAbs response. MVA-BN was safe as well tolerated, with grade 2 reactogenicity higher after the first administration in vaccine-naïve than in vaccine-experienced individuals, but with no evidence for a difference in the duration of these adverse effects. Further studies are needed to evaluate the long-term duration of immunity and to establish specific correlates of protection

Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection. Prospective cohort study

Background: Pre-exposure vaccination with MVA-BN has been widely used against mpox to contain the 2022 outbreak. Many countries have defined prioritized strategies, administering a single dose to those historically vaccinated for smallpox, to achieve quickly adequate coverage in front of low supplies. Using epidemiological models, real-life effectiveness was estimated at approximately 36%-86%, but no clinical trials were performed. Few data on MVA-BN immunogenicity are currently available, and there are no established correlates of protection. Immunological response in PLWH in the context of the 2022 outbreak was also poorly described. Methods: Blood samples were collected from participants eligible for pre-exposure MVA-BN vaccination before (T1) receiving a full course of vaccine (single-dose for vaccine-experienced or smallpox-primed and two-dose for smallpox vaccine-naïve or smallpox non-primed) and one month after the last dose (T2 and T3, respectively). MPXV-specific IgGs were measured by in-house immunofluorescence assay, using 1:20 as screening dilution, MPXV-specific nAbs by 50% plaque reduction neutralization test (PRNT50, starting dilution 1:10), and IFN-γ-producing specific T cells to MVA-BN vaccine, by ELISpot assay. Paired or unpaired t-test and Wilcoxon or Mann-Whitney test were used to analyse IgG and nAbs, and T-cell response, as appropriate. The probability of IgG and nAb response in vaccine-experienced vs. vaccine-naïve was estimated in participants not reactive at T1. The McNemar test was used to evaluate vaccination's effect on humoral response both overall and by smallpox vaccination history. In participants who were not reactive at T1, the proportion of becoming responders one month after full-cycle completion by exposure groups was compared by logistic regression and then analysed by HIV status strata (interaction test). The response was also examined in continuous, and the Average Treatment Effect (ATE) of the difference from baseline to schedule completion according to previous smallpox vaccination was estimated after weighting for HIV using a linear regression model. Self-reports of adverse effects following immunization (AEFIs) were prospectively collected after the first MVA-BN dose (T1). Systemic (S-AEFIs: fatigue, myalgia, headache, GI effects, chills) and local (L-AEFIs: redness, swelling, pain) AEFIs were graded as absent (grade 0), mild (1), moderate (2), or severe (3). The maximum level of severity for S-AEFIs and L-AEFIs ever experienced over the 30 days post-dose by vaccination exposure groups were analysed using a univariable multinomial logistic regression model and after adjusting for HIV status; for each of the symptoms, we also compared the mean duration by exposure group using an unpaired t-test. Findings: Among the 164 participants included, 90 (54.8%) were smallpox vaccine-experienced. Median age was 49 years (IQR 41-55). Among the 76 (46%) PLWH, 76% had a CD4 count &gt;500&nbsp;cells/μL. There was evidence that both the IgG and nAbs titers increased after administration of the MVA-BN vaccine. However, there was no evidence for a difference in the potential mean change in humoral response from baseline to the completion of a full cycle when comparing primed vs. non-primed participants. Similarly, there was no evidence for a difference in the seroconversion rate after full cycle vaccination in the subset of participants not reactive for nAbs at T1 (p&nbsp;=&nbsp;1.00 by Fisher's exact test). In this same analysis and for the nAbs outcome, there was some evidence of negative effect modification by HIV (interaction p-value&nbsp;=&nbsp;0.17) as primed people living with HIV (PLWH) showed a lower probability of seroconversion vs. non-primed, and the opposite was seen in PLWoH. When evaluating the response in continuous, we observed an increase in T-cell response after MVA-BN vaccination in both primed and non-primed. There was evidence for a larger increase when using the 2-dose vs. one-dose strategy with a mean difference of&nbsp;-2.01 log2 (p ≤ 0.0001), after controlling for HIV. No evidence for a difference in the risk of developing any AEFIs of any grade were observed by exposure group, except for the lower risk of grade 2 (moderate) fatigue, induration and local pain which was lower in primed vs. non-primed [OR 0.26 (0.08-0.92), p&nbsp;=&nbsp;0.037; OR 0.30 (0.10-0.88), p&nbsp;=&nbsp;0.029 and OR 0.19 (0.05-0.73), p&nbsp;=&nbsp;0.015, respectively]. No evidence for a difference in symptom duration was also detected between the groups. Interpretation: The evaluation of the humoral and cellular response one month after the completion of the vaccination cycle suggested that MVA-BN is immunogenic and that the administration of a two-dose schedule is preferable regardless of the previous smallpox vaccination history, especially in PLWH, to maximize nAbs response. MVA-BN was safe as well tolerated, with grade 2 reactogenicity higher after the first administration in vaccine-naïve than in vaccine-experienced individuals, but with no evidence for a difference in the duration of these adverse effects. Further studies are needed to evaluate the long-term duration of immunity and to establish specific correlates of protection. Funding: The study was supported by the National Institute for Infectious Disease Lazzaro Spallanzani IRCCS "Advanced grant 5&nbsp;×&nbsp;1000, 2021" and by the Italian Ministry of Health "Ricerca Corrente Linea 2"